Viemed Healthcare, Inc. - Common Shares (VMD)
8.5150
-1.1850 (-12.22%)
NASDAQ · Last Trade: May 6th, 9:43 PM EDT
Viemed (VMD) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
Viemed Healthcare (NASDAQ:VMD) Q1 2026 Earnings: Revenue Beat Offset by EPS Miss and Margin Pressurechartmill.com
Via Chartmill · May 5, 2026
Viemed Healthcare Inc (NASDAQ:VMD) Identified as a CAN SLIM Growth Candidatechartmill.com
Via Chartmill · April 17, 2026
Viemed Healthcare (VMD) exemplifies a high-growth momentum stock, matching strong technical uptrend signals with accelerating fundamental earnings and sales growth.
Via Chartmill · April 13, 2026
CAN SLIM Stock Screener Identifies Growth Leader Viemed Healthcare (NASDAQ:VMD)chartmill.com
Via Chartmill · March 26, 2026
Viemed Healthcare Inc (NASDAQ:VMD) Stands Out as a CAN SLIM Growth Candidatechartmill.com
Via Chartmill · March 5, 2026
Viemed Healthcare Inc (NASDAQ:VMD) Shares Fall After Q4 Revenue Miss and Cautious 2026 Outlookchartmill.com
Via Chartmill · March 4, 2026

Viemed (VMD) Q4 2025 Earnings Call Transcript
Via The Motley Fool · March 5, 2026
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Via Benzinga · September 26, 2025
Via Benzinga · April 28, 2025

Via Benzinga · January 17, 2025

Via Benzinga · December 27, 2024

Via Benzinga · December 16, 2024

VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024

VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via Benzinga · March 6, 2024
